Literature DB >> 18329338

CD83 regulates lymphocyte maturation, activation and homeostasis.

Minka Breloer1, Bernhard Fleischer.   

Abstract

The transmembrane CD83 molecule, a conserved member of the immunoglobulin superfamily, is known as one of the most characteristic cell surface markers for fully matured dendritic cells (DCs) in the peripheral circulation. An essential role for CD83 on murine DCs has not been found; however, evidence shows that its function primarily lies in the regulation of T- and B-lymphocyte maturation and in the regulation of their peripheral responses. Here, we review evidence for a role of CD83 in central lymphocyte maturation and novel, sometimes contradictory findings, regarding the function of CD83 in peripheral immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329338     DOI: 10.1016/j.it.2008.01.009

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  43 in total

1.  CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2.

Authors:  Liwen Chen; Yibei Zhu; Guangbo Zhang; Chao Gao; Weixue Zhong; Xueguang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 2.  Directing T cell fate: How thymic antigen presenting cells coordinate thymocyte selection.

Authors:  Elise R Breed; S Thera Lee; Kristin A Hogquist
Journal:  Semin Cell Dev Biol       Date:  2017-08-09       Impact factor: 7.727

3.  CD83 in Hodgkin lymphoma.

Authors:  Ralf Küppers
Journal:  Haematologica       Date:  2018-04       Impact factor: 9.941

4.  In silico identification of new genetic variations as potential risk factors for Alzheimer's disease in a microarray-oriented simulation.

Authors:  R R Lemos; C H Castelletti; J L Lima Filho; E T Marques; J R M Oliveira
Journal:  J Mol Neurosci       Date:  2009-03-17       Impact factor: 3.444

5.  CD83 polymorphisms and cervical cancer risk.

Authors:  Kelly J Yu; Janet S Rader; Ingrid Borecki; Zhengyan Zhang; Allan Hildesheim
Journal:  Gynecol Oncol       Date:  2009-05-15       Impact factor: 5.482

6.  Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.

Authors:  T A Seldon; R Pryor; A Palkova; M L Jones; N D Verma; M Findova; K Braet; Y Sheng; Y Fan; E Y Zhou; J D Marks; T Munro; S M Mahler; R T Barnard; P D Fromm; P A Silveira; Z Elgundi; X Ju; G J Clark; K F Bradstock; D J Munster; D N J Hart
Journal:  Leukemia       Date:  2015-08-19       Impact factor: 11.528

7.  Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor.

Authors:  Vegard Tjomsland; Anna Spångeus; Per Sandström; Kurt Borch; Davorka Messmer; Marie Larsson
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

8.  HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.

Authors:  Zaruhi Karabekian; Hao Ding; Gulnaz Stybayeva; Irina Ivanova; Narine Muselimyan; Amranul Haque; Ian Toma; Nikki G Posnack; Alexander Revzin; David Leitenberg; Michael A Laflamme; Narine Sarvazyan
Journal:  Tissue Eng Part A       Date:  2015-09-10       Impact factor: 3.845

9.  Soluble CD83 ameliorates experimental colitis in mice.

Authors:  J Eckhardt; S Kreiser; M Döbbeler; C Nicolette; M A DeBenedette; I Y Tcherepanova; C Ostalecki; A J Pommer; C Becker; C Günther; E Zinser; T W Mak; A Steinkasserer; M Lechmann
Journal:  Mucosal Immunol       Date:  2014-01-15       Impact factor: 7.313

10.  Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways.

Authors:  Mireille St-Onge; Aline Dumas; Annick Michaud; Cynthia Laflamme; Andrée-Anne Dussault; Marc Pouliot
Journal:  PLoS One       Date:  2009-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.